Martin Franke

Martin Franke

Auto-generated profile, based on publicly available information

Martin Franke

RG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cell
Verified
Journal Article
Closed access
DLDarío G. Lupiáñez
Darío G. Lupiáñez
KKKaterina Kraft
Katerina Kraft
VHVerena Heinrich
Verena Heinrich
PKPeter Krawitz
Peter Krawitz
FBFrancesco Brancati
Francesco Brancati
SMStefan Mundlos
Stefan Mundlos

5 October 2016 in Nature
Verified
Journal Article
Closed access
MFMartin Franke
Martin Franke
DIDaniel M. Ibrahim
Daniel M. Ibrahim
GAGuillaume Andrey
Guillaume Andrey
WSWibke Schwarzer
Wibke Schwarzer
VHVerena Heinrich
Verena Heinrich
SMStefan Mundlos
Stefan Mundlos

29 July 2019 in Nature Genetics
Verified
Journal Article
Closed access
ADAlexandra Despang
Alexandra Despang
RSRobert Schöpflin
Robert Schöpflin
MFMartin Franke
Martin Franke
SASalaheddine Ali
Salaheddine Ali
IJIvana Jerković
Ivana Jerković
DIDaniel M. Ibrahim
Daniel M. Ibrahim

1 February 2015 in Cell Reports
Verified
Journal Article
Open access
KKKaterina Kraft
Katerina Kraft
SGSinje Geuer
Sinje Geuer
AWAnja J. Will
Anja J. Will
WCWing Lee Chan
Wing Lee Chan
CPChristina Paliou
Christina Paliou
GAGuillaume Andrey
Guillaume Andrey
Structural variations (SVs) contribute to the variability of our genome and are often associated with disease. Their study in model systems was hampered until now by labor-intensive genetic targeting procedures and multiple mouse crossing steps. Here we present the use of CRISPR/Cas for the fast (10 weeks) and efficient generation of SVs in mice. We specifically produced deletions, inversions, and also duplications at six different genomic loci ranging from 1.1 kb to 1.6 Mb with efficiencies up to 42%. After PCR-based selection, clones were successfully used to create mice via aggregation. To test the practicability of the method, we reproduced a human 500 kb disease-associated deletion and were able to recapitulate the human phenotype in mice. Furthermore, we evaluated the regulatory potential of a large genomic interval by deleting a 1.5 Mb fragment. The method presented permits rapid in vivo modeling of genomic rearrangements.

27 September 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBjørt K. Kragesteen
Bjørt K. Kragesteen
MSMalte Spielmann
Malte Spielmann
CPChristina Paliou
Christina Paliou
VHVerena Heinrich
Verena Heinrich
RSRobert Schöpflin
Robert Schöpflin
GAGuillaume Andrey
Guillaume Andrey

1 October 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MSMalte Spielmann
Malte Spielmann
FBFrancesco Brancati
Francesco Brancati
PKPeter M. Krawitz
Peter M. Krawitz
PRPeter N. Robinson
Peter N. Robinson
DIDaniel M. Ibrahim
Daniel M. Ibrahim
SMStefan Mundlos
Stefan Mundlos